AANG Holdings Group Member
We specialize in delivering cutting-edge "smart" information systems, solutions and consultancy services tailored for life sciences and healthcare. Our mission is to revolutionize the biospecimen landscape by pioneering patient-centric strategies and operational methodologies that cater to the entire human biospecimen ecosystem.
Our strength lies in our diverse and tightly-knit team, boasting years of collective experience, working in harmony since 2018. What sets us apart is the fusion of scientific expertise from the life sciences and technological prowess, resulting in a powerhouse of innovation. This unique blend, not only fuels the creation of groundbreaking services, but also facilitates seamless navigation through the intricate realms of both digital and biological landscapes. Driven by a passion for excellence, we continuously strive to push the boundaries of what's possible in biotechnology. Our team of experts is dedicated to staying ahead of the curve, leveraging the latest advancements in technology and research to deliver unparalleled solutions.
With a commitment to collaboration and innovation, we empower our clients to unlock new insights and achieve breakthroughs in their respective fields. Join us at the forefront of discovery and together, let's shape the future of Life Sciences. At Metabio, we're trailblazers in biosample innovation, streamlining the drug development process, and providing state-of-the-art personalized medicine tools. Our versatile platforms boast the capability to seamlessly collect, store, and even source longitudinal data associated with human biosamples. What sets us apart are our services, which are exploration-friendly, integration-capable, GDPR & HIPAA compliant and fully customizable and versatile.
Metabio solidies its presence in Thessaloniki as a Private Equity Company (Metabio PC), commencing the realization of our digital vision.
Metabio partners with Anthology Ventures and completes its first Angel Investment round.
Metabio's investors re-invest with a follow on investment that gives the opportunity to set up headquarters at Agisilaou 4, Thessaloniki.
Our American subsidiary, Metabio USA INC, is formed as a Delaware corporation.
EU patent office PCT application, for the system and method for management of medical, biodiagnostic data and biospecimen in Biobanking enviroment.
e-MetaBio platform is created, with all four subplatforms and services.
Metabio successfully, closes its pre-seed investment round of 190k euros.
Metabio BG, is incoporated in Sofia, Bulgaria and its scope of activities is focused on Software sales and business development in the Balkans.
Metabio BG, recieves investment is incoporated in Sofia, Bulgaria and its scope of activities is focused on Software sales and business development in the Balkans.
Metabio is selected for the TRUSTCAHIAN open call 3, for the creation of our own and the first European DLT Life Science Marketplace for the Biosample Usage chain.
Metabio's strategic investor, one of the fastest growing firm in Greece and Europe, AANG Holding Group, has oversubscribed our investment ask for the round, demonstrating strong confidence in Metabio’s vision.
Our “e-MetabAIo” project submitted under the Horizon Europe EIC call has received the Seal of Excellence from the European Commission, recognizing it as a high-impact, high-quality proposal.
Metabio Acquired 80% of the American based startup LockSign LLC. With LockSign's technology all Metabio's platforms are allowed for asignature that cannot be copied or forged as it is unique to the specific document or user.
At Metabio, we foster a culture built on integrity, inclusion, and impact. We believe that a diverse and empowered team is essential to driving innovation in biobanking and life sciences. Our work environment encourages open dialogue, mutual respect, and active collaboration, ensuring that every voice is heard and valued.
Aligned with our values, Metabio is deeply committed to environmental sustainability, social responsibility, and strong governance. Through responsible innovation, we, as a company, aim to minimize environmental impact, promote equitable access to healthcare, and uphold the highest standards of data security and ethical compliance. Our integrated ESG approach ensures that our technologies not only advance biomedical research but also contribute positively to society and the planet, supporting a more transparent, inclusive, and sustainable future in life sciences.
Metabio specializes in delivering innovative IT solutions and consultancy services tailored for the biobanking, life sciences, and healthcare sectors. Our mission is to revolutionize the biospecimen landscape by pioneering patient-centric strategies and operational methodologies that cater to the entire human biospecimen ecosystem. Our vision is to pioneer in biosample innovation, streamlining the drug development process, and providing state-of-the-art personalized medicine tools.
At Metabio, we follow an end-to-end approach that transforms needs into measurable outcomes. We begin by working on-site with your team to map value needs, identify requirements, and design the ideal architecture for your operations.
Once the foundation is clear, we implement e-MetaBio® either as a secure cloud-based solution or locally within an in-situ white box, ensuring seamless integration, scalability, and robustness.
Beyond implementation, we remain a long-term partner, providing continuous services that accelerate business performance and adapt our platforms with a fit-for-purpose mentality, helping you raise KPIs, optimize workflows, and unlock lasting value.
We use cookies to improve your browsing experience, analyze our traffic, and provide certain features. By clicking “Accept all,” you consent to the use of cookies in accordance with our Privacy Policy.
